Healthcare
Fried Frank represents multinational corporations on industry-shaping healthcare transactions. With longstanding relationships in the industry, we partner with clients on sophisticated transactions across the evolving healthcare landscape. Our clients include prominent pharmaceutical companies, leading health insurance providers, global medical technology and device providers, and premier investors, including private equity sponsors.
Our experience with healthcare companies spans all sizes—from growth stage to multibillion-dollar corporations—which broadens our perspective and enhances our offering to support our clients throughout their entire lifecycle, including:
- Strategic investments
- Innovative capital raising
- Transformative M&A
- Precedent-setting litigation
In addition to large corporations, our connections with leading private equity sponsors, healthcare-specific REITs and investment banks gives us valuable industry insight. We are proud of our role in shaping the future of the healthcare industry, having handled healthcare transactions surpassing $150 billion in the past two years alone.
Significant Matters:
- CVS Health
- $8 billion acquisition of Signify Health.
- $1.9 billion acquisition of Target’s pharmacy and clinic business.
- Acquisition of the retail and specialty pharmacy business of Schnuck Markets.
- Sales of Coventry Workers Comp Services and bswift.
- Catalent
- $1 billion acquisition of Bettera Holdings.
- $1.2 billion acquisition of Paragon Bioservices.
- $950 million acquisition of Cook Pharmica.
- $475 million acquisition of Metrics Contract Services.
- Acquisitions of Redwood Bioscience, Micron Technologies, Accucaps Industries Limited, MaSTherCell Global and Vaccine Manufacturing and Innovation Centre UK Limited.
- Becton, Dickinson and Company
- Acquisition of TVA Medical.
- Acquisition of Scanwell Health Inc.
- Acquisition of ZebraSci, Inc.
- Acquisition of Tepha, Inc.
- Humana, Inc.
- $4.1 billion acquisition of Kindred Healthcare.
- $600 million joint venture with Welsh, Carson, Anderson & Stowe in Partners in Primary Care.
- $1.4 billion acquisition of Curo Health Services.
- Perrigo
- In federal and state high stakes securities litigations.
- $4.35 billion financing of its acquisition of Elan Corp.
- Billions of dollars of securities offerings.
- Merck
- $14.2 billion sale of its consumer care business to Bayer.
- $35+ billion in securities offerings.
News and insight
Client memorandum |
DOJ Announces New Data-Sharing Partnerships Amid $6.5 Billion Health Care Fraud Takedown⟶Special Report |
Healthcare – False Claims and Antitrust Violations⟶Client memorandum |
Prescription for Scrutiny: Antitrust Focus on Private Equity Investments in Healthcare⟶Antitrust and Competition Law Alert® |
The Top Four Antitrust Enforcement Issues in Healthcare Today⟶Media mentions |
Bernard (Barry) A. Nigro Jr. Quoted by Global Competition Review⟶